查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
傷口敷料去除劑的全球市場 - 2022-2029
市場調查報告書
商品編碼
1140693

傷口敷料去除劑的全球市場 - 2022-2029

Global Wound Debridement Products Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期間（2022-2029 年），傷口敷料的市場規模預計將以 5.9% 的複合年增長率增長。

傷口敷料是從人體傷口中去除異物、死組織和有害物質的過程。傷口敷料去除劑產品有助於減少干擾傷口癒合的有害物質。

市場動態

全球傷口敷料市場的驅動力是人口老齡化加劇、糖尿病相關傷口發病率上升、燒傷率上升、產品技術進步以及對傷口護理治療和管理的認識提高。該計劃的驅動力通過肥胖水平的增長和報銷政策。

預計產品的技術進步將推動市場增長。

一次性使用負壓療法 (NPWT) 的引入正在取得進展，主要是在家庭護理領域。此外，超聲設備的推出有望推動傷口清創產品市場。超聲波設備具有諸如區分不易腐爛和易腐爛組織的能力等優點。這些設備有助於破壞生物膜和細菌，而不會損壞血管。同樣在 2019 年 8 月 13 日，赫瑞瓦特大學的工程師開發了一種微型電子傳感器，可以幫助醫務人員通過“聽到”傷口來治癒傷口。這種微型傳感器有助於監測繃帶下組織的微觀變化。

此外，正在進行的研究活動有望□□提振市場。例如，最近由俄亥俄州立大學的一組研究人員於 2019 年 3 月在線發表在《科學報告》雜誌上的一項研究發現，電療繃帶可以殺死傷口周圍的細菌，使傷口癒合得更快，據說可以治愈。通過這種方式，產品的技術進步和研究活動的增加將推動市場增長。

約束

然而，傷口敷料產品的高成本和接受傷口敷料劑後可能出現的並發症正在阻礙市場。例如，出血、機械傷口敷料產品去除健康組織以及可能因污染引起的感染等並發症可能會限制市場。

行業分析

傷口敷料去除劑市場根據各種行業因素（包括未滿足的需求、定價分析、供應鏈分析和監管分析）對市場進行了深入分析。

細分分析

在傷口敷料去除劑市場中，凝膠部分預計將佔據最大的市場份額。

凝膠部分將在 2021 年佔據最大的市場份額。好處包括無刺激性、出血少和安□□全去除死組織而不感染。使用凝膠的研究活動也可能會刺激市場。此外，越來越多的手術傷口和手術部位感染 (SSI) 患者、慢性傷口（尤其是糖尿病足潰瘍）發病率的上升是導致該細分市場增長的主要因素。例如，基於 CS 的水凝膠因其生物相容性和對病原微生物的活性而在傷口癒合中得到了廣泛的關注。 Ferreira 等人開發並表徵了用洗必泰（2% 和 4%）配製的 CS 凝膠系統。當應用金黃色葡萄球菌菌株時，這種水凝膠系統的抗菌特性和癒合活性可抑制 100% 的細菌生長。因此，對這種凝膠的需求正在增加。因此，根據上述描述，預計這種市場細分將在預測期內佔據最大的市場份額。

區域分析

預計北美將佔據全球傷口敷料去除劑市場的最大市場份額。

2021 年，北美市場份額最大。由於產品創新、傷口病例增加、醫療保健支出增加以及該地區人口老齡化的增加，這些都是預測期內的驅動因素。例如，美國國立衛生研究院估計，65 歲以上的人口中有 3% 最終會出現傷口。在資源匱乏的國家和其他傷口和潰瘍普遍存在的地區，預計發病率會更高。因此，越來越多的傷口正在推動市場。

此外，預計該地區主要參與者對傷口管理的持續研究活動將推動市場發展。 Cedars-Sinai Health System 的 Brennan Spiegel 及其同事於 2019 年 8 月 14 日在開放獲取期刊 PLOS ONE 上發表的一項研究發現，治療性虛擬現實 (VR) 可以減輕傷口護理期間的疼痛、焦慮症、成為一種積極的非藥理學分散患者註意力的方式已經很明顯。因此，正在進行的研究活動的存在推動了市場。因此，從以上描述來看，預計北美地區在預測期內將佔據最大的市場份額。

競爭格局

傷口敷料市場的主要參與者有 B. Braun Melsungen AG、Acelity L.P. Inc.、Smith & Nephew、Coloplast A/S、ConvaTec Group、Paul Hartmann、Molnlycke Health Care、Lohmann & Rauscher、Medline Industries 和 Integra生命科學。

B. Braun Melsungen GmbH

B.Braun 是一家德國醫療器械和藥品製造商。 B. Braun 的產品範圍包括 5,000 種產品，其中 95% 是內部製造的。公司的產品組合包括輸液、營養和疼痛產品、輸液泵和系統、手術器械、縫合材料、髖關節和膝關節植入物、透析機和配件、造口術、消毒和傷口護理產品。它通過五個部門運營：醫院護理、Aesculap、B.Brown Avitam、門診市場 (OPM) 和其他分銷。 B.Brown 在 64 個國家/地區開展業務，並在醫療保健行業的 18 個治療領域開發產品。

產品組合

Askina 紗布壓縮，消毒。 Askina 紗布壓縮是一種無菌紗布壓縮，通過折疊切割端而設計。由 100% 棉製成。

好處

  • 吸水性好
  • 讓空氣通過
  • 柔軟柔軟
  • 提供 8 層或 12 層。

全球傷口敷料去除劑市場報告提供對大約 45 多個市場數據表和 40 多個圖表的訪問。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按產品劃分的市場細分
  • 按傷口類型劃分的市場細分
  • 按方法劃分的市場細分
  • 最終用戶的市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 糖尿病和肥胖症的增加
      • 產品中的技術進步
    • 限制因素
      • 去除傷口敷料後的潛在並發症
    • 商機
    • 影響分析

第5章行業分析

  • 波特五力分析
  • 監管分析
  • 供應鏈分析
  • 定價分析
  • 未滿足的需求分析

第 6 章按產品分類

  • 凝膠
    • 超聲波設備
    • 手術器械
    • 軟膏/乳霜
    • 醫用紗布
    • 機械清創墊
    • 其他

第 7 章按傷口類型

  • 燒傷
  • 糖尿病足潰瘍
  • 褥瘡
  • 靜脈性腿部潰瘍
  • 手術傷口和外傷
  • 其他

第8章方法

  • 手術方式
  • □法
  • 自溶法
  • 機械法
  • 其他

第 9 章，最終用戶

  • 專科診所
  • 醫院
  • 居家護理
  • 其他

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 競爭場景
  • 市場定位/市場份額分析
  • 併購分析

第 12 章公司簡介

  • B.Braun Melsungen AG。
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Acelity L.P., Inc.
  • Smith & Nephew
  • Coloplast A/S
  • ConvaTec Group
  • Paul Hartmann
  • Molnlycke Health Care
  • Lohmann & Rauscher
  • Medline Industries
  • Integra Lifesciences.（"List not exhaustive"）

第13章 重要考察

第14章 DataM

簡介目錄
Product Code: DMMD1730

Market Overview

Wound Debridement Products Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.9% during the forecast period (2022-2029).

Wound Debridement is a process to eliminate foreign invaders, dead tissues, and toxic substances from human wounds. Wound Debridement Products products aid in lowering the poisonous materials that prevent the wounds from getting healed.

Market Dynamics

The global wound Debridement Products Market is driven by the increase in the aging population, rise in prevalence of diabetes and associated wounds, an increasing number of burn injuries, technological advancements in products, awareness programs for wound care treatment and management, growth in obesity levels and reimbursement policies.

The technological advancements in the products are expected to drive the market growth.

The introduction of single-use negative pressure therapy (NPWT), primarily in-home care settings, is gaining traction. Further, the introduction of ultrasonic devices is expected to drive the wound Debridement Products market. Ultrasonic devices offer benefits like the capacity to differentiate between non-viable and viable tissues. These devices aid in destroying biofilms and bacteria without causing damage to blood vessels. Also, on August 13, 2019, Engineers at Heriot-Watt University developed a tiny electronic sensor that will help medics to heal wounds by "listening" to them. The microsensor aids in monitoring the tiny, microscale changes in tissue that are taking place below the bandages.

Moreover, ongoing research activities are expected to boost the market. For instance, in March 2019, a study published online recently in the journal Scientific Reports by a research team at Ohio State University stated that electroceutical bandages could kill the bacteria around a wound, allowing the wounds to heal faster. Thus, technological advancements in the products and a growing number of research activities drive market growth.

Restraint:

However, the high cost of Debridement Products products and the possible complications after undergoing wound debridement products are hampering the market. For instance, complications such as bleeding, removal of healthy tissues by mechanical Debridement Products, and chances of infection through contamination are likely to restrain the market.

Industry Analysis

The wound debridement products market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

Gels segment is expected to hold the largest market share in the wound debridement products market.

The gels segment accounted for the largest market share in 2021. The segment benefits from the advantages, including no inflammation, reduced bleeding, and safe removal of necrotic tissues without causing infection. Also, research activities using gels are likely to bolster the market. Moreover, increasing cases of surgical wounds or Surgical Site Infection (SSI) among patients and rising incidence of chronic wounds, especially diabetic foot ulcers, are among the major factors contributing to the segment growth. For instance, CS-based hydrogels have been intensively engaged in wound healing since they are biocompatible and present activity against pathogenic microorganisms. Ferreira et al. developed and characterized a CS gel system associated with chlorhexidine (2% and 4%). This hydrogel system's antibacterial properties and healing activity showed 100% inhibition of bacterial growth when strain S. aureus was applied. Therefore, there is an increase in the demand for the gel. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global wound debridement products market.

North America accounted for the largest market share in 2021. Owing to the product innovations, an increasing number of wound cases, increasing healthcare spending, and the growing aging population in this region are the factors to drive in the forecast period. For instance, the National Institute of Health has estimated that 3% of the population 65 years and above would have a wound at some time. An even higher incidence rate is expected, owing to the traumatic injuries and ulcers endemic in resource-poor countries to other regions. Thus, the rising number of wounds is driving the market.

Moreover, the ongoing research activities for wound management by the key players in the region are expected to boost the market. A study published on August 14, 2019, in the open-access journal PLOS ONE by Brennan Spiegel of Cedars-Sinai Health System and colleagues found that therapeutic virtual reality (VR) is emerging as an active, non-pharmacological treatment modality for pain, anxiety disorders, and distract patients during wound care. Thus, the presence of ongoing research activities is driving the market. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the wound debridement products market are B. Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew, Coloplast A/S, ConvaTec Group, Paul Hartmann, Molnlycke Health Care, Lohmann & Rauscher, Medline Industries, and Integra Lifesciences.

B. Braun Melsungen AG:

B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, pain therapy products, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, ostomy, disinfection, and wound care products. The company operates its business through five divisions: hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM) and other sales. B. Braun has a presence in 64 countries and develops products in 18 therapy fields of the healthcare industry.

Product Portfolio:

Askina Gauze Compress, sterile: Askina Gauze Compress is a sterile gauze compress designed with cut edges folded. It is made of 100% cotton.

Advantages

  • Good absorbency
  • Permeable to air
  • Soft and supple
  • Available at 8-PLY or 12-PLY.

The global wound debridement products market report would provide an access to an approx. 45+market data table, 40+figures

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Wound type
  • 3.3. Market Snippet by Method
  • 3.4. Market Snippet by End-user

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Rising incidence of diabetes and obesity
      • 4.1.1.2. The presence of technological advancements in products
    • 4.1.2. Restraints
      • 4.1.2.1. The possible complications after wound debridement
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Market Attractiveness Index, By Product type Segment
  • 6.2. Gels*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
    • 6.2.3. Ultrasonic Devices
    • 6.2.4. Surgical devices
    • 6.2.5. Ointments and Creams
    • 6.2.6. Medical Gauze
    • 6.2.7. Mechanical Debridement ProductsPads
    • 6.2.8. Others

7. By Wound type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 7.1.2. Market Attractiveness Index, By Wound type Segment
  • 7.2. Burns*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 7.3. Diabetic Foot Ulcers
  • 7.4. Pressure Ulcers
  • 7.5. Venous Leg Ulcers
  • 7.6. Surgical & Traumatic Wounds
  • 7.7. Others

8. By Method

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 8.1.2. Market Attractiveness Index, By Method Segment
  • 8.2. Surgical Method*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 8.3. Enzymatic Method
  • 8.4. Autolytic Method
  • 8.5. Mechanical Method
  • 8.6. Others

9. By End-user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user Segment
    • 9.1.2. Market Attractiveness Index, By End-user Segment
  • 9.2. Specialty Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
  • 9.3. Hospitals
  • 9.4. Home care
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. The U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. The Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. B. Braun Melsungen AG.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Acelity L.P., Inc.
  • 12.3. Smith & Nephew
  • 12.4. Coloplast A/S
  • 12.5. ConvaTec Group
  • 12.6. Paul Hartmann
  • 12.7. Molnlycke Health Care
  • 12.8. Lohmann & Rauscher
  • 12.9. Medline Industries
  • 12.10. Integra Lifesciences. ("List not exhaustive")

13. Premium Insights

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us